Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YAZ versus placebo for moderate acne in women
2014-004612-10Phase 3
- Sponsor
- Bayer
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acne vulgaris comparing YAZ with Placebo (2 arms). Primary endpoint: Percent change from baseline to Cycle 6 in total lesion count.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2014-004612-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004612-10.